CARDIOCYCLE R&D LIMITED

CARDIOCYCLE R&D Ltd. is a Galway‑based medical‑device company dedicated to turning cutting‑edge concepts into tangible solutions for cardiovascular disease. With an experienced engineering team at its core, the firm focuses on research and development of state‑of‑the‑art devices that aim to address the global burden of heart‑related conditions – a leading cause of death, responsible for 17.9 million fatalities each year.

The company’s specialisation lies in creating innovative cardiovascular technologies that can help curb the projected $1 trillion healthcare cost of CVD in the United States by 2035 and tap into the $50.87 billion global market for such devices. By combining rigorous scientific expertise with a clear vision for the future, CARDIOCYCLE R&D serves healthcare providers, clinicians and patients worldwide, delivering solutions that strive to improve outcomes and reduce the impact of heart disease. Their commitment to R&D positions them as a forward‑looking partner in the fight against one of the world’s most pressing health challenges.